| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CSPC Pharmaceutical Group Limited (HK: 1093)
1093 Technical Analysis
1.5
| As on 20th May 2025 1093 STOCK Price closed @ 6.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.22 & Sell for SHORT-TERM with Stoploss of 6.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1093STOCK Price
| Open | 6.17 | Change | Price | % |
| High | 6.51 | 1 Day | 0.36 | 6.06 |
| Low | 6.16 | 1 Week | 0.56 | 9.76 |
| Close | 6.30 | 1 Month | 0.82 | 14.96 |
| Volume | 332435850 | 1 Year | -0.55 | -8.03 |
| 52 Week High 7.33 | 52 Week Low 4.34 | ||||
HK Hong Kong Most Active Stocks
| CSHK100 | 2077.44 | 1.36% |
| 1060 | 0.61 | 29.79% |
| 43 | 1.14 | 0.00% |
| 0139 | 0.03 | 0.00% |
| 0939 | 6.93 | 1.17% |
| 1093 | 6.30 | 6.06% |
| 3988 | 4.68 | 0.86% |
| 0460 | 0.82 | 5.13% |
| 460 | 0.82 | 5.13% |
| 1530 | 19.18 | 32.28% |
HK Hong Kong Top Gainers Stocks
HK Hong Kong Top Losers Stocks
| 1093 Daily Charts |
1093 Intraday Charts |
Whats New @ Bazaartrend |
1093 Free Analysis |
|
|
1093 Important Levels Intraday
| RESISTANCE | 6.97 |
| RESISTANCE | 6.76 |
| RESISTANCE | 6.62 |
| RESISTANCE | 6.49 |
| SUPPORT | 6.11 |
| SUPPORT | 5.98 |
| SUPPORT | 5.84 |
| SUPPORT | 5.63 |
1093 Forecast May 2025
| 4th UP Forecast | 9.79 |
| 3rd UP Forecast | 8.67 |
| 2nd UP Forecast | 7.98 |
| 1st UP Forecast | 7.29 |
| 1st DOWN Forecast | 5.31 |
| 2nd DOWN Forecast | 4.62 |
| 3rd DOWN Forecast | 3.93 |
| 4th DOWN Forecast | 2.81 |
1093 Weekly Forecast
| 4th UP Forecast | 7.13 |
| 3rd UP Forecast | 6.86 |
| 2nd UP Forecast | 6.70 |
| 1st UP Forecast | 6.53 |
| 1st DOWN Forecast | 6.07 |
| 2nd DOWN Forecast | 5.90 |
| 3rd DOWN Forecast | 5.74 |
| 4th DOWN Forecast | 5.47 |
1093 Forecast2025
| 4th UP Forecast | 13.16 |
| 3rd UP Forecast | 10.96 |
| 2nd UP Forecast | 9.6 |
| 1st UP Forecast | 8.24 |
| 1st DOWN Forecast | 4.36 |
| 2nd DOWN Forecast | 3 |
| 3rd DOWN Forecast | 1.64 |
| 4th DOWN Forecast | -0.56 |
CSPC Pharmaceutical Group Limited ( HK Hong Kong Symbol : 1093 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1093 Business Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke and memory and mental impairment; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Xuanning for hypertension; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; Enxi to treat adult idiopathic Parkinson's disease; Keaili for breast cancer; Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; and Encun to prevent atherosclerotic thrombosis events. It also offers Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; Gaoshunsong for arthritis, rheumatoid, and various pain; Debixin for various ulcer; and Qimaite for acute and chronic pains. In addition, the company provides antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and researches and develops various products with focus on the therapeutic areas of oncology, autoimmunity, psychiatry and neurology, digestion and metabolism, cardio-cerebrovascular system, and anti-infection. Further, it offers healthcare services and sells pharmaceutical equipment. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China. Address: No. 226 Huanghe Street, Shijiazhuang, China, 050035
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service